Home › Ewing Sarcoma › Texas › Dallas
Ewing Sarcoma clinical trials in Dallas, TX
3 studies for Ewing Sarcoma are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Children's Medical Center, Dallas
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- Children's Medical Center, Dallas
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
RecruitingPhase 1/2
- Children's Health Dallas, Dallas
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Philadelphia, PA7 studies
- Houston, TX7 studies
- Memphis, TN7 studies
- Los Angeles, CA6 studies
- Aurora, CO6 studies
- Boston, MA6 studies
- Washington, DC6 studies
- Birmingham, AL5 studies
- Atlanta, GA5 studies
- Phoenix, AZ4 studies
- Cincinnati, OH4 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer52 studies
- Heart Failure43 studies
- Metastatic Cancer42 studies
- Cancer (all types)38 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity31 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.